CN104530086B - 头孢孟多酯钠化合物的新晶型及其结晶制备方法 - Google Patents
头孢孟多酯钠化合物的新晶型及其结晶制备方法 Download PDFInfo
- Publication number
- CN104530086B CN104530086B CN201410784492.8A CN201410784492A CN104530086B CN 104530086 B CN104530086 B CN 104530086B CN 201410784492 A CN201410784492 A CN 201410784492A CN 104530086 B CN104530086 B CN 104530086B
- Authority
- CN
- China
- Prior art keywords
- product
- suspension
- crystal
- sodium
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 *CC1*=**(*[U]=C)=C1 Chemical compound *CC1*=**(*[U]=C)=C1 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/12—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (9)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410784492.8A CN104530086B (zh) | 2014-12-16 | 2014-12-16 | 头孢孟多酯钠化合物的新晶型及其结晶制备方法 |
PCT/CN2015/095229 WO2016095660A1 (zh) | 2014-12-16 | 2015-11-20 | 头孢孟多酯钠化合物新晶型及其制剂和制备方法 |
US15/305,661 US20170050982A1 (en) | 2014-12-16 | 2015-11-20 | New crystalline form of cefamandole sodium compound, formulation and preparation method thereof |
US15/687,359 US9834567B1 (en) | 2014-12-16 | 2017-08-25 | Crystalline form of cefamandole nafate compound, preparation and preparing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410784492.8A CN104530086B (zh) | 2014-12-16 | 2014-12-16 | 头孢孟多酯钠化合物的新晶型及其结晶制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104530086A CN104530086A (zh) | 2015-04-22 |
CN104530086B true CN104530086B (zh) | 2015-12-09 |
Family
ID=52845752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410784492.8A Active CN104530086B (zh) | 2014-12-16 | 2014-12-16 | 头孢孟多酯钠化合物的新晶型及其结晶制备方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20170050982A1 (zh) |
CN (1) | CN104530086B (zh) |
WO (1) | WO2016095660A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104844625A (zh) * | 2015-05-08 | 2015-08-19 | 天津大学 | 头孢孟多酯钠的一种新晶型及其结晶制备方法 |
CN104844626A (zh) * | 2015-05-08 | 2015-08-19 | 天津大学 | 头孢孟多酯钠的新晶型及其结晶制备方法 |
CN104829631A (zh) * | 2015-05-08 | 2015-08-12 | 天津大学 | 一种头孢孟多酯钠的新晶型及其结晶制备方法 |
CN107915750B (zh) * | 2017-11-28 | 2019-09-24 | 华北制药河北华民药业有限责任公司 | 一种头孢孟多酯钠粉针制剂的制备方法 |
CN110734455A (zh) * | 2018-07-20 | 2020-01-31 | 罗欣药业(上海)有限公司 | 一种头孢孟多酯钠新晶型及其制备方法 |
CN113754717A (zh) * | 2021-10-15 | 2021-12-07 | 南京高新工大生物技术研究院有限公司 | 一种还原型谷胱甘肽α型晶体的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3947415A (en) * | 1974-12-23 | 1976-03-30 | Eli Lilly And Company | Cefamandole derivatives |
US4168376A (en) * | 1978-06-05 | 1979-09-18 | Eli Lilly And Company | Process for crystalline sodium cefamandole |
CN101914106A (zh) * | 2010-08-20 | 2010-12-15 | 湖北济生医药有限公司 | 头孢孟多酯钠水合物及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4006138A (en) * | 1975-04-11 | 1977-02-01 | Eli Lilly And Company | Crystalline form of sodium O-formylcefamandole |
US4035361A (en) * | 1976-03-17 | 1977-07-12 | Eli Lilly And Company | Bis-trimethylsilyl cefamandole and process therefor |
US8586781B2 (en) * | 1998-04-02 | 2013-11-19 | Mbc Pharma, Inc. | Bone targeted therapeutics and methods of making and using the same |
CN103044453B (zh) * | 2013-01-22 | 2014-07-30 | 湖北济生医药有限公司 | 头孢孟多酯钠化合物及其药物组合物 |
CN103145736B (zh) * | 2013-03-29 | 2014-04-30 | 四川省惠达药业有限公司 | 一种含有头孢孟多酯钠化合物的药物组合物 |
CN104844625A (zh) * | 2015-05-08 | 2015-08-19 | 天津大学 | 头孢孟多酯钠的一种新晶型及其结晶制备方法 |
CN104829631A (zh) * | 2015-05-08 | 2015-08-12 | 天津大学 | 一种头孢孟多酯钠的新晶型及其结晶制备方法 |
-
2014
- 2014-12-16 CN CN201410784492.8A patent/CN104530086B/zh active Active
-
2015
- 2015-11-20 US US15/305,661 patent/US20170050982A1/en not_active Abandoned
- 2015-11-20 WO PCT/CN2015/095229 patent/WO2016095660A1/zh active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3947415A (en) * | 1974-12-23 | 1976-03-30 | Eli Lilly And Company | Cefamandole derivatives |
US4168376A (en) * | 1978-06-05 | 1979-09-18 | Eli Lilly And Company | Process for crystalline sodium cefamandole |
CN101914106A (zh) * | 2010-08-20 | 2010-12-15 | 湖北济生医药有限公司 | 头孢孟多酯钠水合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104530086A (zh) | 2015-04-22 |
US20170050982A1 (en) | 2017-02-23 |
WO2016095660A1 (zh) | 2016-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104530086B (zh) | 头孢孟多酯钠化合物的新晶型及其结晶制备方法 | |
CN102558182B (zh) | 一种厄他培南钠晶型及其制备方法 | |
CN102924483B (zh) | 一种头孢他啶晶体化合物、其制备方法及其无菌混合粉形式的药物组合物 | |
CN101812076B (zh) | 头孢呋辛钠及其制备方法 | |
CN102659818B (zh) | 一种盐酸头孢替安晶体化合物及其制备方法及含该化合物的药物组合物 | |
CN104844625A (zh) | 头孢孟多酯钠的一种新晶型及其结晶制备方法 | |
CN101967156B (zh) | 一种头孢呋辛钠重结晶的方法 | |
CN103102357B (zh) | 一种头孢呋辛钠的合成方法 | |
AU597262B2 (en) | Cephalosporin salts and injectable compositions | |
WO2017140074A1 (zh) | 盐酸头孢甲肟新晶型及制剂 | |
CN103304582B (zh) | 一种头孢西丁钠的化合物、其制备方法及其药物组合物 | |
CN103601739A (zh) | 一种头孢西丁钠化合物及其制备方法 | |
CN104829631A (zh) | 一种头孢孟多酯钠的新晶型及其结晶制备方法 | |
CN104829673A (zh) | 一种索氟布韦晶型6的制备方法 | |
CN106317080A (zh) | 一种采用耦合结晶技术制备的头孢他啶化合物及其制剂 | |
CN104844626A (zh) | 头孢孟多酯钠的新晶型及其结晶制备方法 | |
CN103012437A (zh) | 抗菌药物头孢西丁酸的制备方法 | |
CN104926834A (zh) | 一种小儿用头孢曲松钠化合物实体及其制剂 | |
CN104327098B (zh) | 一种头孢他美酸二异丙胺盐 | |
US9637502B2 (en) | Crystal form of Cefathiamidine compound and preparation method therefor | |
WO2017140073A1 (zh) | 一种采用粒子过程晶体产品分子组装与形态优化技术的头孢硫脒新晶型化合物及制剂 | |
US9834567B1 (en) | Crystalline form of cefamandole nafate compound, preparation and preparing method thereof | |
CN109096309B (zh) | 一种43/4水头孢他啶化合物及其药物组合物 | |
CN101829119B (zh) | 头孢地秦钠组合物及其粉针 | |
CN101759708A (zh) | 头孢地嗪钠晶型及其制备方法和含有该晶型的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Hao Hongxun Inventor after: Xie Chuang Inventor after: Bao Ying Inventor after: Tao Linggang Inventor after: He Fang Inventor after: Hou Baohong Inventor after: Wang Jingkang Inventor after: Lv Jun Inventor after: Yin Qiuxiang Inventor after: Wang Yongli Inventor after: Gong Junbo Inventor before: Hao Hongxun Inventor before: Bao Ying Inventor before: Tao Linggang Inventor before: He Fang Inventor before: Hou Baohong Inventor before: Lv Jun Inventor before: Yin Qiuxiang Inventor before: Wang Yongli Inventor before: Gong Junbo Inventor before: Xie Chuang |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |